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Abstract
Objective: The WHO recommends a daily Ca intake for postmenopausal women
of 1300mg. The objective of the present study was to assess the dietary Ca intake
in European postmenopausal osteoporotic women.
Design, setting and subjects: Assessment of dietary Ca intake (food and supple-
ments) was performed with a validated self-questionnaire in 8524 osteoporotic
women from nine European countries (Belgium, Denmark, France, Germany,
Hungary, Italy, Poland, Spain and the UK).
Results: Mean age of the patients was 74?2 (SD 7?1) years, mean BMI was 25?7 (SD
4?2) kg/m2. Of the study population, 37?2% of the women took Ca supplements.
The mean dietary intake of Ca was 930?7 (SD 422?9) mg/d. The lowest Ca intake
was found in Hungary (586?7 (SD 319?1) mg/d) and the highest in Denmark
(1145?6 (SD 463?0) mg/d). In the whole study population, only 19?1% of the
women had a dietary Ca intake .1300mg/d. Only 17?1% of women aged over
75 years achieved 1300mg/d compared with 20?5% of women aged less than
75 years (P5 0?0001 for the difference between the two groups).
Conclusion: Dietary intake of Ca is very low in European postmenopausal






Osteoporosis is characterized by increased skeletal fragi-
lity and susceptibility to fractures, leading to a significant
increase in morbidity and mortality(1). Because of the
ageing of the European population, a preventive strategy
for osteoporosis has become a public health priority.
Ca is an essential nutrient that plays a vital role in
neuromuscular function, many enzyme-mediated pro-
cesses, blood clotting, and provides rigidity to the skele-
ton by virtue of its phosphate salts(2). Ca consumption
also influences the maintenance of bone mass(3). Nearly
all (i.e. 99%) of total body Ca is located in the skeleton
and the remaining 1% is equally distributed between the
teeth and soft tissues, with only 0?1% in the extracellular
compartment(2,4).
The Ca needs for adults are generally recognized as the
intake required to maintain Ca balance and, therefore,
skeletal integrity(2,5). The Recommended Dietary Allowance
(RDA) for European adults is 800mg/d(6). After meno-
pause, Ca requirements increase to at least 1000mg/d(7,8).
The WHO recommendation for European postmenopausal
women is 1300mg/d(2,3).
The objective of the present study was to assess the
daily dietary Ca intake in European postmenopausal
osteoporotic women.
Methods
Postmenopausal women aged over 50 years were inclu-
ded in the study. These women were part of a run-in
study aimed at normalizing the Ca and vitamin D status of
osteoporotic patients prior to their inclusion in a trial
investigating the anti-fracture efficacy of a new anti-
osteoporotic drug. Patients were considered osteoporotic
if their lumbar spine or femoral neck bone mineral den-
sity was at least 2?5 standard deviations below the median
T-score.
The present study involved 8524 patients from nine
European countries: Belgium (n 1193), Denmark (n 327),
France (n 1290), Germany (n 373), Hungary (n 353), Italy
(n 1233), Poland (n 1544), Spain (n 590) and the UK
(n 1621).
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Assessment of Ca intake was performed with a previously
validated self-questionnaire(9). This questionnaire enables
evaluation of the Ca content of the diet of an individual on
the basis of twenty different types of food (items) rich in Ca
and/or frequently eaten. Obviously, tablets of Ca taken as
supplements were also considered. Our study population
was divided into three categories of Ca consumption:
,800mg/d, 800–1300mg/d and .1300mg/d. These
thresholds were fixed according to the RDA for European
adults (800mg/d)(6) and the WHO recommendation for
European postmenopausal women (1300mg/d)(2).
Results
The mean age of the 8524 women included in the present
study was 74?2 (SD 7?1) years, mean BMI was 25?7 (SD 4?2)
kg/m2. Table 1 shows the characteristics of the patients
according to category of dietary Ca intake (i.e. ,800mg/d,
800–1300mg/d, .1300mg/d).
In the whole study population, 37?2% of the women
took Ca supplements (34?9% of women aged over 75
years and 38?9% of women aged less than 75 years).
Mean daily food intake was significantly lower
(P, 0.001) in subjects who did not take a Ca supplement.
The mean dietary Ca intake (food plus supplements)
was 930?7 (SD 422?9) mg/d. Only 19?1% of women
(n 1628) had daily dietary Ca consumption .1300mg.
Moreover, 39?4% (n 3360) of the study population had
daily Ca dietary intake of 800–1300mg and 41?5%
(n 3536) had an intake of ,800mg daily (Fig. 1).
Daily Ca intake from food and supplements, stratified
by country, is shown in Table 2. The highest level of daily
Ca intake from food was found in Denmark (1145?6mg/d)
and the smallest in Hungary (586?7mg/d). Figure 2 shows
the proportions of women in the different countries accord-
ing to intake category (i.e. ,800mg/d, 800–1300mg/d,
.1300mg/d).
We found the lowest dietary Ca inadequacy in women
aged over 75 years compared with women aged less than
75 years (P, 0?0001). Only 17?1% of women aged over
75 years achieved 1300mg/d compared with 20?5%
of women aged less than 75 years (P5 0?0001 for the
difference between the two groups) (Fig. 1).
Discussion
We have shown that the mean dietary Ca intake of Eur-
opean postmenopausal osteoporotic women was below
the WHO recommendation. The majority of these women
(41?5%) took less Ca than that recommended for adults
before menopause (800mg/d) and only 19?1% of them
achieved the WHO recommendation (1300mg/d) for this
population. The level of daily Ca intake from food varied
across different European countries but always remained
below the WHO-recommended intake.
Table 1 Baseline characteristics of women according to category of dietary calcium intake: European postmenopausal osteoporotic women
,800mg/d 800–1300mg/d .1300mg/d
Characteristic Mean SD Mean SD Mean SD
n 3536 3360 1628
Age (years) 74?8 7?3 74?1 7?0 73?3 6?7
BMI (kg/m2) 26?0 4?3 25?7 4?1 25?3 4?0
Lumbar spine BMD (g/cm2) 0?77 0?13 0?77 0?13 0?77 0?13
Femoral neck BMD (g/cm2) 0?55 0?08 0?55 0?08 0?56 0?08
25-Hydroxycalciferol (nmol/l) 57?7 27?1 62?7 27?1 64?8 26?7
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Fig. 1 Proportion of women in the global population, women
aged less than 75 years and women more than 75 years of age
meeting different thresholds ( ,,800mg/d;&, 800–1300mg/d;
, .1300mg/d) of dietary calcium intake: European post-
menopausal osteoporotic women
Table 2 Dietary calcium intake and the percentage of women
taking calcium supplements in different countries: European post-
menopausal osteoporotic women
Dietary Ca intake (mg/d)
n Mean SD Supplements (%)
Belgium 1193 791?8 394?7 45?5
Denmark 327 1145?6 463?0 33?6
France 1290 1019?4 392?2 46?5
Germany 373 1060?7 470?1 53?9
Hungary 353 586?7 319?0 16?7
Italy 1233 945?1 380?0 41?9
Poland 1544 693?9 367?0 20?1
Spain 590 1074?3 374?2 64?2
UK 1621 1126?6 373?9 28?4
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Other epidemiological studies have described low
dietary Ca intake. In 131 healthy postmenopausal women
aged 64?7 (SD 7?6) years, Andon et al. found mean Ca
consumption of 606 (SD 302) mg/d(10). In late ($5 years)
postmenopausal women, Jensen et al.(11) described mean
Ca consumption of 793 (SD 280) mg/d in women aged
65 years and older. In 184 elderly women aged over
65 years, Pfister et al.(12) found a mean dietary Ca intake
of 563.4mg/d. The combined dietary Ca intake and
supplement Ca intake in elderly women (.60 years old)
participating in NHANES III (Third National Health and
Nutrition Examination Survey) was 864 (SD 16) mg/d(13).
In a recent study, the mean dietary Ca intake reported by
167 postmenopausal women aged 40–65 years was 924
(SD 347) mg/d(14).
Subjects included in the present study were women
being screened for taking part in a study assessing the anti-
fracture efficacy of a new anti-osteoporotic drug in post-
menopausal osteoporosis. Other studies performed in such
populations (i.e. screening for randomized controlled trials
of anti-osteoporotic drugs) also described low Ca intake in
postmenopausal osteoporotic women(15–20). For example,
in 1637 postmenopausal women with prior vertebral frac-
tures, mean daily intake of Ca from food ranged from
675mg to 786mg in the different randomized groups(19).
In the baseline characterization of the Fracture Interven-
tion Trial(16), the mean Ca intake was 619mg/d for the
placebo group (n 1005) and 652mg/d for the treatment
group (n 1022).
In the present study, we have shown that the daily
intake of Ca from food was low and that only 37?2% of
the women took Ca supplements. Foods provide the best
way to meet the Ca requirement because they constitute
good sources of other essential nutrients(3). However,
dietary Ca intake has been found to be dependent on
socio-economic status(21) and personal attitudes towards
food (i.e. milk)(12). Moreover, it is difficult to achieve
vitamin and mineral requirements when daily energy
intake is below 6?28MJ (1500 kcal)(22–24). Thus different
expert groups have recommended use of Ca supplements
by postmenopausal osteoporotic women(25–27). In the
present study, it appeared that women who took Ca
supplements had higher mean daily Ca intake from food
(P, 0.001) compared with women who did not take
supplements, probably because of a greater awareness of
their osteoporosis disease.
Osteoporotic fractures occur predominantly in popula-
tions aged over 65 years(28). Elderly populations have
lower daily intakes of vitamins and minerals compared
with younger populations(29), partly because of a lower
food intake. In the present study, we found the highest
dietary Ca inadequacy in women aged less than 75 years
compared with women aged over 75 years. Only 17?1% of
women aged over 75 years achieved 1300mg Ca/d com-
pared with 20?5% of women aged less than 75 years.
We used the WHO recommendation for postmenopausal
women to set up a threshold of 1300mg/d, but the
National Institutes of Health consensus group recommends
a Ca consumption of at least 1500mg/d after 65 years(8,30).
Our results confirm the difficulty in achieving correct daily
Ca intake by food consumption alone in old post-
menopausal women. Unfortunately, it should be pointed
out that only 36?8% of these women used Ca supplements.
In the present study we assessed dietary Ca intake of
a population screened prior to inclusion in a trial investi-
gating the anti-fracture efficacy of an anti-osteoporotic
drug. Because of the patient inclusion/exclusion criteria
in this particular study, our population cannot be repre-
sentative of the general population but more of an
osteoporotic population starting a treatment.
Another limitation of the study relates to the Ca intake
assessment, which was performed with a validated self-
questionnaire(9). However, it should be pointed that some
studies have found that some dietary recalls and records
could have an underestimation of 25–30%. However,
even if our data are underestimated, our conclusion that
dietary Ca intake is very low in European post-
menopausal women is still true and could even be more
serious.
Osteoporosis and its consequences are a serious public
health problem in the ageing population(1,31). Our study
shows insufficient dietary Ca intakes in postmenopausal
osteoporotic women (whatever the age) in nine Eur-
opean countries. A substantial part of our study popula-
tion does not achieve the general recommendation for
Ca intake in such a population. We believe that greater
awareness of this public health problem could help the
fight against osteoporosis.
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Fig. 2 Proportion of women in different European countries
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